60 DEGREES PHARMACEUTICALS, INC. - 8-K Filing
60 Degrees Pharmaceuticals updated its investor presentation and announced an interim data readout for hospitalized babesiosis study. (Items: 7.01 Regulation FD Disclosure On October 6, 2026, the Company updated its investor presentation, which it intends to use from time to time in meet, 8.01 Other Events, 9.01 Financial Statements and Exhibits (a) Exhibits Number Description 99)
Tickers: $SXTP